These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2421965)
21. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Greene DA; Sima AA; Stevens MJ; Feldman EL; Killen PD; Henry DN; Thomas T; Dananberg J; Lattimer SA Diabetes Metab Rev; 1993 Oct; 9(3):189-217. PubMed ID: 8187607 [No Abstract] [Full Text] [Related]
22. Substrate properties of analogs of myo-inositol. Moyer JD; Reizes O; Ahir S; Jiang C; Malinowski N; Baker DC Mol Pharmacol; 1988 Jun; 33(6):683-9. PubMed ID: 2837638 [TBL] [Abstract][Full Text] [Related]
23. [Pathogenesis of diabetic neuropathies]. Lalau JD; Arlot S; Quichaud J Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874 [TBL] [Abstract][Full Text] [Related]
24. Polyols and myo-inositol in diabetic neuropathy--of mice and men. Tomlinson DR Mayo Clin Proc; 1989 Aug; 64(8):1030-3. PubMed ID: 2796398 [No Abstract] [Full Text] [Related]
25. Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve. Greene DA; Lattimer SA Am J Physiol; 1984 Apr; 246(4 Pt 1):E311-8. PubMed ID: 6326584 [TBL] [Abstract][Full Text] [Related]
26. Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Greene DA Metabolism; 1983 Jul; 32(7 Suppl 1):118-23. PubMed ID: 6306391 [TBL] [Abstract][Full Text] [Related]
27. [Perspective for the treatment of diabetic neuropathy: translation from molecular studies to bedside]. Yagihashi S; Yamagishi S; Wada R Rinsho Shinkeigaku; 2005 Nov; 45(11):966-8. PubMed ID: 16447775 [TBL] [Abstract][Full Text] [Related]
28. Characterization of reactions catalysed by yeast phosphatidylinositol synthase. Klezovitch O; Brandenburger Y; Geindre M; Deshusses J FEBS Lett; 1993 Apr; 320(3):256-60. PubMed ID: 8385029 [TBL] [Abstract][Full Text] [Related]
29. Significance of myo-inositol concentrations in metabolic regulation. Simmons DA; Winegrad AI; Martin DB Trans Assoc Am Physicians; 1982; 95():292-8. PubMed ID: 7182982 [No Abstract] [Full Text] [Related]
34. [New theories of the pathogenesis of diabetic neuropathies]. Lekishvili VP Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612 [No Abstract] [Full Text] [Related]
35. Biochemical alterations and complications in diabetes. Greene DA; Lattimer SA Clin Chem; 1986 Oct; 32(10 Suppl):B42-7. PubMed ID: 3019590 [No Abstract] [Full Text] [Related]
36. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells. Imoto M; Taniguchi Y; Fujiwara H; Umezawa K Exp Cell Res; 1994 May; 212(1):151-4. PubMed ID: 7909754 [TBL] [Abstract][Full Text] [Related]
37. Early effect of myo-inositol deficiency on phosphatidylinositol metabolism in rat liver. Anderson LL; Trinh M; Flick PK Biochim Biophys Acta; 1987 Feb; 917(2):341-3. PubMed ID: 3026487 [TBL] [Abstract][Full Text] [Related]
38. Organization of the phosphoinositide cycle. Assessment of inositol transferase activity in purified plasma membranes. Santiago OM; Rosenberg LI; Monaco ME Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):179-83. PubMed ID: 8382477 [TBL] [Abstract][Full Text] [Related]
39. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. Winegrad AI; Greene DA N Engl J Med; 1976 Dec; 295(25):1416-21. PubMed ID: 980097 [No Abstract] [Full Text] [Related]
40. Contribution of axonal transport to the renewal of myelin phospholipids in peripheral nerves. I. Quantitative radioautographic study. Droz B; Di Giamberardino L; Koenig HL Brain Res; 1981 Aug; 219(1):57-71. PubMed ID: 6167331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]